https://www.selleckchem.com/products/ml-7.html
Among patients with no and at least one exacerbation within the preceding 12 months, 30% and 26%, respectively, had a blood-eosinophil count ≥ 0.3 × 10 /L. In patients with two or more exacerbations within the last 12 months, 77% had a blood-eosinophil count of ≥ 0.1 × 10 /L. Furthermore, 166 patients (11%) had at least one hospital admission due to COPD exacerbation, and a blood-eosinophil count of ≥ 0.1 × 10 /L. This study of a large cohort of COPD patients currently prescribed inhaled corticosteroids suggests the need for re-evaluating
Aimer
Commentaire
Partagez
